Bracket announced its first acquisition since launching last month. Arrowhead Electronic Healthcare, a global provider of electronic Patient-Reported Outcome (ePRO) technologies, will join Bracket. Bracket is committed to building a broad platform of technology tools to improve how pharmaceutical research and development is conducted. Handheld ePRO is a natural complement to Bracket’s existing eClinical platform.
UBC launched Bracket, a Specialty Services provider last month. Adam Butler, vice president at UBC and who is spearheading Bracket, told Applied Clinical Trials: "We formed Bracket on the premise that a comprehensive re-examination of how pharmaceutical research and development is conducted was required. I think it's clear that the combination of technology tools and clinical expertise will be a core part of how we improve R&D, and I expect to see an increasing focus on improving the way we integrate technology into these programs." For more on the Bracket launch, listen to this podcast.
As part of the Arrowhead acquisition,
· Arrowhead’s ePRO solutions will be integrated into Bracket’s existing suite of eClinical tools, including IVRS, IWRS, and e-Learning platforms.
· Arrowhead's ePRO solutions are uniquely engineered to better capture the true patient experience in clinical studies so trial sponsors can focus on making better, faster drug development decisions.
· Independent research indicates sharp increases in the adoption and use of handheld ePRO tools in clinical trials over the next two years.
· Arrowhead's ePRO-LOG™ software platform is used on smartphones, tablet computers, the Web, and text messaging applications.
Arrowhead’s trademarked technologies include:
· ePRO-LOG™ Smartphone
· Ideal for frequently administering questionnaires and when portability and alarm reminders are essential.
· ePRO-LOG™ Tablet
· Excellent for studies where content is dense, moderate portability is needed, and Internet availability is limited. ePRO-LOG™ Tablet can be deployed at site or patients' homes; many Quality of Life questionnaires are good candidates for tablet computers.
· ePRO-LOG™ Web
· ePRO-LOG™ Web works well on studies with dense content and where patients have regular access to Web sites or 3G Web-enabled phones. ePRO-LOG™ Web can be administered at home or in clinic; many Quality of Life questionnaires are good candidates for Web.
· ePRO-LOG™ SMS
· Optimal for simple data logging and alert notifications, ePRO-LOG™ SMS is highly mobile and relatively inexpensive.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.